Ovarian carcinoma diagnosis - PubMed (original) (raw)
Ovarian carcinoma diagnosis
B A Goff et al. Cancer. 2000.
Abstract
Background: Ovarian carcinoma often is called the "silent killer" because the disease usually is not detected until an advanced stage. The authors' goal was to evaluate preoperative symptoms and factors that may contribute to delayed diagnosis for women with ovarian carcinoma.
Methods: A two-page survey was distributed to 1500 women who subscribe to CONVERSATIONS!, a newsletter about ovarian carcinoma. Because the survey could be copied and given to other patients, 1725 surveys were returned from women in 46 states and 4 Canadian provinces.
Results: The median age of the surveyed women was 52 years, and 70% had Stage III or IV disease (International Federation of Gynecology and Obstetrics). When asked about symptoms before the diagnosis of ovarian carcinoma, 95% reported symptoms, which were categorized as abdominal (77%), gastrointestinal (70%), pain (58%), constitutional (50%), urinary (34%), and pelvic (26%). Only 11% of women with Stage I/II and 3% with Stage III/IV reported no symptoms before their diagnosis. Women who ignored their symptoms were significantly more likely to be diagnosed with advanced disease compared with those who did not (P = 0.002). The time required for a health care provider to make the diagnosis was reported as less than 3 months by 55%, but greater than 6 months by 26% and greater than 1 year by 11%. Factors significantly associated with delay in diagnosis were omission of a pelvic exam at first visit; having a multitude of symptoms; being diagnosed initially with no problem, depression, stress, irritable bowel, or gastritis; not initially receiving an ultrasound, computed tomography, or CA 125 test; and younger age. The type of health care provider seen initially, insurance, and specific symptoms did not correlate with delayed diagnosis.
Conclusions: This large national survey confirms that the majority of women with ovarian carcinoma are symptomatic and frequently have delays in diagnosis.
Copyright 2000 American Cancer Society.
Similar articles
- Reducing time to diagnosis does not improve outcomes for women with symptomatic ovarian cancer: a report from the Australian Ovarian Cancer Study Group.
Nagle CM, Francis JE, Nelson AE, Zorbas H, Luxford K, de Fazio A, Fereday S, Bowtell DD, Green AC, Webb PM. Nagle CM, et al. J Clin Oncol. 2011 Jun 1;29(16):2253-8. doi: 10.1200/JCO.2010.32.2164. Epub 2011 May 2. J Clin Oncol. 2011. PMID: 21537035 - Women's awareness of ovarian cancer risks and symptoms.
Lockwood-Rayermann S, Donovan HS, Rambo D, Kuo CW. Lockwood-Rayermann S, et al. Am J Nurs. 2009 Sep;109(9):36-45; quiz 46. doi: 10.1097/01.NAJ.0000360309.08701.73. Am J Nurs. 2009. PMID: 19704232 - Frequency of symptoms of ovarian cancer in women presenting to primary care clinics.
Goff BA, Mandel LS, Melancon CH, Muntz HG. Goff BA, et al. JAMA. 2004 Jun 9;291(22):2705-12. doi: 10.1001/jama.291.22.2705. JAMA. 2004. PMID: 15187051 - Symptoms and diagnosis of borderline, early and advanced epithelial ovarian cancer.
Webb PM, Purdie DM, Grover S, Jordan S, Dick ML, Green AC. Webb PM, et al. Gynecol Oncol. 2004 Jan;92(1):232-9. doi: 10.1016/j.ygyno.2003.09.005. Gynecol Oncol. 2004. PMID: 14751164 - Ovarian cancer: the neglected diagnosis.
Yawn BP, Barrette BA, Wollan PC. Yawn BP, et al. Mayo Clin Proc. 2004 Oct;79(10):1277-82. doi: 10.4065/79.10.1277. Mayo Clin Proc. 2004. PMID: 15473410
Cited by
- Duodenal obstruction in a 38-year-old: Case report of an unusual ovarian cancer presentation requiring a Whipple procedure.
Somasegar S, Tostrud L, Poultsides G, Renz M. Somasegar S, et al. Heliyon. 2024 Aug 19;10(16):e36581. doi: 10.1016/j.heliyon.2024.e36581. eCollection 2024 Aug 30. Heliyon. 2024. PMID: 39262961 Free PMC article. - Global publication productivity and research trends on recurrent ovarian cancer: a bibliometric study.
Xu H, Wang L, Xu D. Xu H, et al. Front Oncol. 2024 Jul 5;14:1422213. doi: 10.3389/fonc.2024.1422213. eCollection 2024. Front Oncol. 2024. PMID: 39035742 Free PMC article. - Enigma of Ovarian Cancer - Early detection Challenges and Solutions!
Pradeep Y. Pradeep Y. J Midlife Health. 2024 Jan-Mar;15(1):3-4. doi: 10.4103/jmh.jmh_52_24. Epub 2024 Apr 4. J Midlife Health. 2024. PMID: 38764930 Free PMC article. No abstract available. - RPL35A drives ovarian cancer progression by promoting the binding of YY1 to CTCF promoter.
Wu H, Xia L, Sun L, Li D, Liu X, Song H, Sheng J, Wang K, Feng Q. Wu H, et al. J Cell Mol Med. 2024 Mar;28(6):e18115. doi: 10.1111/jcmm.18115. J Cell Mol Med. 2024. PMID: 38436544 Free PMC article. - From seeds to survival rates: investigating Linum usitatissimum's potential against ovarian cancer through network pharmacology.
Islam MM, Sreeharsha N, Alshabrmi FM, Asif AH, Aldhubiab B, Anwer MK, Krishnasamy R, Rehman A. Islam MM, et al. Front Pharmacol. 2023 Oct 30;14:1285258. doi: 10.3389/fphar.2023.1285258. eCollection 2023. Front Pharmacol. 2023. PMID: 37964873 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical
Research Materials